Lonza Group AG Total Liabilities
Lonza Group AG total liabilities. Based on the latest financial reports, Lonza Group AG (LONN) has total liabilities worth CHF10.11 Billion CHF (≈ $12.78 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Lonza Group AG liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Lonza Group AG (2004–2025)
Total liabilities of Lonza Group AG from 2004 to 2025. This chart illustrates how Lonza Group AG's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Lonza Group AG's assets to evaluate the company's liquid asset resilience ratio.
Lonza Group AG Competitors by Total Liabilities
The table below lists competitors of Lonza Group AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Endesa SA
MC:ELE
|
Spain | €30.09 Billion |
|
Mahindra & Mahindra Limited
NSE:M&M
|
India | Rs2.08 Trillion |
|
KOMATSU LTD. SPONS. ADR 1
F:KOMA
|
Germany | €2.54 Trillion |
|
Bank of Communications Co. Ltd
F:C4C
|
Germany | €14.97 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF5.15 Billion |
|
PT BK CE.AS.ADR/25 RP625
F:BZG
|
Germany | €1305.14 Trillion |
|
Beijing-Shanghai High Speed Railway Co Ltd
SHG:601816
|
China | CN¥57.48 Billion |
|
Saab AB (publ)
ST:SAAB-B
|
Sweden | Skr85.02 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Lonza Group AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Lonza Group AG balance sheet assets.
Liquidity & Leverage Metrics
Lonza Group AG Total Liabilities Ratios Explained
Lonza Group AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lonza Group AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lonza Group AG (2004–2025)
The table below shows the annual total liabilities of Lonza Group AG from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CHF9.78 Billion ≈ $12.36 Billion |
-5.46% |
| 2024-12-31 | CHF10.35 Billion ≈ $13.08 Billion |
+41.02% |
| 2023-12-31 | CHF7.34 Billion ≈ $9.27 Billion |
+9.64% |
| 2022-12-31 | CHF6.69 Billion ≈ $8.46 Billion |
+0.83% |
| 2021-12-31 | CHF6.64 Billion ≈ $8.39 Billion |
-14.27% |
| 2020-12-31 | CHF7.74 Billion ≈ $9.79 Billion |
+6.39% |
| 2019-12-31 | CHF7.28 Billion ≈ $9.20 Billion |
-4.65% |
| 2018-12-31 | CHF7.63 Billion ≈ $9.65 Billion |
-0.25% |
| 2017-12-31 | CHF7.65 Billion ≈ $9.67 Billion |
+71.03% |
| 2016-12-31 | CHF4.47 Billion ≈ $5.66 Billion |
+8.75% |
| 2015-12-31 | CHF4.11 Billion ≈ $5.20 Billion |
-4.59% |
| 2014-12-31 | CHF4.31 Billion ≈ $5.45 Billion |
+1.51% |
| 2013-12-31 | CHF4.25 Billion ≈ $5.37 Billion |
-9.52% |
| 2012-12-31 | CHF4.69 Billion ≈ $5.93 Billion |
+0.64% |
| 2011-12-31 | CHF4.66 Billion ≈ $5.90 Billion |
+95.06% |
| 2010-12-31 | CHF2.39 Billion ≈ $3.02 Billion |
-6.42% |
| 2009-12-31 | CHF2.56 Billion ≈ $3.23 Billion |
-18.71% |
| 2008-12-31 | CHF3.14 Billion ≈ $3.97 Billion |
0.00% |
| 2007-12-31 | CHF3.14 Billion ≈ $3.97 Billion |
+36.36% |
| 2006-12-31 | CHF2.31 Billion ≈ $2.91 Billion |
-18.87% |
| 2005-12-31 | CHF2.84 Billion ≈ $3.59 Billion |
+38.18% |
| 2004-12-31 | CHF2.06 Billion ≈ $2.60 Billion |
-- |
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biol… Read more